Skip to main content
Log in

Synthesis, characterization, in vitro hydrolysis and pharmacodynamic profiles of potential novel mutual prodrugs of N-(2,3-xylyl anthranilic acid)

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In present research work, we report the synthesis, in vitro hydrolysis study and pharmacological evaluation of new mutual prodrugs of mefenamic acid (MA) and 1,2 dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenylpyrazol-3-one with the aim of improving the therapeutic potency and retard the adverse effects of gastrointestinal origin. The structure of the synthesized mutual ester prodrugs (MP1 and MP2) were confirmed by IR, 1H NMR, 13C NMR, mass spectroscopy and their formation was confirmed by TLC. The purity of the synthesized compounds was established by elemental analysis. The title compounds were tested for analgesic activity by acetic acid-induced writhing method; anti-inflammatory activity was tested by carrageenan-induced rat paw edema method and ulcerogenicity. The study of the analgesic activity revealed that both prodrugs (MP1 and MP2) have shown significant reduction (81.67, 63.90 %) in writhing response produced by acetic acid as compared to parent drug MA (61.10 %). Both mutual prodrugs showed better maximum anti-inflammatory effects (71.43, 85.71 %) and for longer time as compared to parent drug MA (53.14 %). The synthesized prodrugs were also found to be very less irritating to gastric mucosal membrane than parent drugs. The kinetics of ester hydrolysis was studied in simulated gastric fluid (SGF) at pH 1.2 and simulated intestinal fluid (SIF) at pH 7.4. The release of free MA from prodrugs showed negligible hydrolysis in SGF as compared to SIF. This indicated that prodrugs were sufficiently stable at pH 1.2 and do not break in the stomach, but release MA in SIF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Scheme 2
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bhosale AV, Agrawal GP, Mishra P (2004) Preparation and characterization of mutual prodrugs of ibuprofen. Ind J Pharm Sci 66:158–163

    CAS  Google Scholar 

  • Bhosle D, Bharambe S, Gairola N, Dhaneshwar SS (2006) Mutual prodrug concept: fundamentals and applications. Indian J Pharm Sci 68(3):286–294

    Article  CAS  Google Scholar 

  • Buckley MM, Brogden RN (1990) Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 39(1):86–109

    Article  CAS  PubMed  Google Scholar 

  • Croft DN, Cuddigan JHP, Sweetland C (1972) Gastric bleeding and benorylate, a new aspirin. Br Med J 3:545–547

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Dhaneshwar SS, Chaturvedi SC (1994) Synthesis and biological evaluation of ketoprofen glycinate methyl ester: a prodrug concept-part1. Indian Drugs 31(8):374–377

    CAS  Google Scholar 

  • Dhaneshwar SS, Dhaneshwar SR, Chaturvedi SC (1995) Synthesis and biological evaluation of histidine conjugate of diclofenac: a prodrug approach. Eastern Pharm 38:119–122

    CAS  Google Scholar 

  • Gairola N, Nagpal D, Dhaneshwar SR, Dhaneshwar SS, Chaturvedi SC (2005) Synthesis, kinetics and pharmacodynamic profiles of novel prodrugs of flurbiprofen. Ind J Pharm Sci 67:369–373

    CAS  Google Scholar 

  • Koster R, Anderson M, De-Beer EJ (1959) Acetic acid analgesic screen. Fed Proc 18:418–420

    Google Scholar 

  • Kunchandy J, Khanna S, Kulkarni SK (1984) Effect of α2 agonists clonidine, guanfacine and β-HT 920 on gastric acid secretion and ulcer in the rats. Arch Int Pharmacodyn 275:123–128

    Google Scholar 

  • Lucius M, Brueing in Hoechst, AM (1907) Patentiert im Deutschen Reiche vom Patentschift Nr. 206637, Klasse 12p, Gruppe 8

  • Meyers J, Braine E, Moonka DK, Davis RH (1979) The effect of selected amino acids on gelatine-induced inflammation in adult male mice. Inflammation 3(3):225–233

    Article  CAS  PubMed  Google Scholar 

  • Robert TS, Ronald JV (1989) Synthesis and anti-inflammatory activity of n-aryl anthranilic acid and its derivatives. Amer J Med 86:449

    Article  Google Scholar 

  • Shah K, Shrivastava SK, Mishra P (2013) Evaluation of mefenamic acid mutual prodrugs. Med Chem Res 22(1):70–77

    Article  CAS  Google Scholar 

  • Sheha M, Khedr A, Elsherief H (2002) Biological and metabolic study of naproxen-propyphenazone mutual prodrug. Eur J Pharm Sci 17:121–130

    Article  CAS  PubMed  Google Scholar 

  • Steinmeyer J (2000) Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res 2(5):379–385

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Velingkar VS, Desai DM, Panda VS (2011) Synthesis, characterisation, computational ADME studies, pharmacological screening and in vitro hydrolysis studies of potential novel mutual prodrugs of N-(2,3-xylyl anthranilic acid). Int J Drug Des Discov 2(3):548–558

    CAS  Google Scholar 

  • Winter CA, Risley EA, Nuss GW (1962) Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors express their thanks to Vani Pharma Labs Limited, Hyderabad (Andhra Pradesh), India, for providing gift sample of propyphenazone. The authors are grateful to Head of Department, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak (Haryana), India, for providing the necessary facilities to carry out this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sucheta Ohlan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohlan, S., Nanda, S. & Pathak, D.P. Synthesis, characterization, in vitro hydrolysis and pharmacodynamic profiles of potential novel mutual prodrugs of N-(2,3-xylyl anthranilic acid). Med Chem Res 22, 5120–5128 (2013). https://doi.org/10.1007/s00044-013-0516-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-013-0516-5

Keywords

Navigation